Signaling Gateway - 2 May 2008
http://ealerts.nature.com/cgi-bin24/DM/y/ekdF0Xztnp0H2W0M40Es
*********************************************************************
Signaling Update is a one-stop online resource designed to keep you 
in touch with the latest and most exciting research in cell 
signaling. New content is uploaded every Friday.
*********************************************************************
In Signaling Update this week:
------------------------
Featured Article
------------------------
ONCOGENIC TRANSFORMATION: INVASION OF THE MICROVESICLES
Glioma cells that express the oncogenic receptor EGFRvIII form 
microvesicles that fuse with neighboring, non-transformed cells to 
promote their oncogenic transformation.
Original research paper: Nature Cell Biology 10, 619-624 (2008)
http://ealerts.nature.com/cgi-bin24/DM/y/ekdF0Xztnp0H2W0vP0E2
------------------------
Molecule Pages
------------------------
The Molecule Pages: A comprehensive, relational, signaling database. 
Each week we highlight an expert-authored, peer-reviewed Molecule Page.
http://ealerts.nature.com/cgi-bin24/DM/y/ekdF0Xztnp0H2W0HIE0EJ
Rac2
http://ealerts.nature.com/cgi-bin24/DM/y/ekdF0Xztnp0H2W0BuEQ0EI
Rac2 is a member of the Rho family of small GTPases. Rac2 regulates 
a number of cellular functions by cycling between its inactive 
GDP-bound state and its active GTP-bound state. Rac2 has been shown 
to preferentially regulate phagocyte NADPH oxidase by directly 
interacting with it and the regulatory protein p67-phox. The Rac2 
knockout mouse exhibits chemotaxis defects due to interactions with 
unknown cytoskeletal effectors.
Search the Molecule Pages
http://ealerts.nature.com/cgi-bin24/DM/y/ekdF0Xztnp0H2W0BUuz0EF
-------------------
Selected Updates
-------------------
CELL MIGRATION: GROUP VOYAGE
Collective cell migration - the movement of cells in clusters, 
strands, sheets and tubes - is regulated by an evolutionarily 
conserved cascade that involves the Jun N-terminal kinase (JNK) 
signaling pathway.
Original research paper: Curr. Biol. 18, 532–537 (2008)
http://ealerts.nature.com/cgi-bin24/DM/y/ekdF0Xztnp0H2W0BuER0EJ
TUMOUR IMMUNOLOGY: TUMOUR SURVEILLANCE BY NKG2D
The expression of natural-killer group 2, member D (NKG2D) stimulatory 
receptor ligands is known to render tumor cells susceptible to NK-cell 
killing, and NKG2D has now been found to have an important role in 
tumor surveillance in spontaneous cancer models in vivo.
Original research paper: Immunity 28, 571–580 (2008)
http://ealerts.nature.com/cgi-bin24/DM/y/ekdF0Xztnp0H2W0BuES0EK
THERAPY: BAD TO THE BONE
Suppressing the hedgehog signaling pathway in cancers has potential 
therapeutic value; however, suppressing this pathway in young mice 
results in permanent and detrimental skeletal changes.
Original research paper: Cancer Cell 13, 249–260 (2008)
http://ealerts.nature.com/cgi-bin24/DM/y/ekdF0Xztnp0H2W0BuET0EL
More Updates:
http://ealerts.nature.com/cgi-bin24/DM/y/ekdF0Xztnp0H2W0vO0E1
------------------------
Research Library
------------------------
HIERARCHICAL STRUCTURE AND THE PREDICTION OF MISSING LINKS IN 
NETWORKS
Nature 453, 98-101 (2008)
http://ealerts.nature.com/cgi-bin24/DM/y/ekdF0Xztnp0H2W0BuEU0EM
ANGIOPOIETINS ASSEMBLE DISTINCT Tie2 SIGNALLING COMPLEXES IN 
ENDOTHELIAL CELL-CELL AND CELL-MATRIX CONTACTS
Nature Cell Biology 10, 527-537  (2008)
http://ealerts.nature.com/cgi-bin24/DM/y/ekdF0Xztnp0H2W0BuEV0EN
BAC TRANSGENEOMICS: A HIGH-THROUGHPUT METHOD FOR EXPLORATION OF 
PROTEIN FUNCTION IN MAMMALS
Nature Methods 5, 409-415 (2008)
http://ealerts.nature.com/cgi-bin24/DM/y/ekdF0Xztnp0H2W0BuEW0EO
------------------------
Signaling News
------------------------
UCSD-NATURE SIGNALING GATEWAY: SUPPORT THE SITE!
http://ealerts.nature.com/cgi-bin24/DM/y/ekdF0Xztnp0H2W0BqCO0EA
Help keep the Signaling Gateway free! We would like to apply for 
continued funding for this project from the US National Institutes of 
Health. Please show your support for the Signaling Gateway by writing 
a letter to us via this web form. Your response will help keep the 
content on the site freely available for all users.
More News
http://ealerts.nature.com/cgi-bin24/DM/y/ekdF0Xztnp0H2W0Crw0Ej
-------------------------
Gateway Updates
-------------------------
THE CELL MIGRATION GATEWAY - MAY UPDATE
http://ealerts.nature.com/cgi-bin24/DM/y/ekdF0Xztnp0H2W0ll80EH
The Cell Migration Update is a comprehensive FREE online resource to 
keep you abreast of the latest findings in the field.
This month's update features 
Mammary development: Collective migration without protrusions
http://ealerts.nature.com/cgi-bin24/DM/y/ekdF0Xztnp0H2W0BuEX0EP
and
Differential signalling: For quiescence or for migration?
http://ealerts.nature.com/cgi-bin24/DM/y/ekdF0Xztnp0H2W0BuEY0EQ
Sign up to receive the monthly table of contents e-alert for the 
Cell Migration Update.
http://ealerts.nature.com/cgi-bin24/DM/y/ekdF0Xztnp0H2W0BJrg0Eg
-----------------------------
Signaling Job of the Week
-----------------------------
Science Manager and Postdoctoral Scientist
Employer: Otto von Guericke University Magdeburg
Location: Magdeburg, Germany
http://ealerts.nature.com/cgi-bin24/DM/y/ekdF0Xztnp0H2W0BuEZ0ER
A Science Manager position and a Postdoctoral position are available 
at the Institute of Experimental Internal Medicine at the Otto von 
Guericke University, Magdeburg. The Science Manager will contribute to 
patent and grant applications, lab management and the development of 
innovative research strategies. The Postdoctoral scientist will use 
mathematical models of signal transduction to study NF-kappaB 
signaling in inflammation and tumor biology.
More Jobs:
http://ealerts.nature.com/cgi-bin24/DM/y/ekdF0Xztnp0H2W0BnjC0EY
To advertise a job in this spot, please contact Naturejobs.
http://ealerts.nature.com/cgi-bin24/DM/y/ekdF0Xztnp0H2W0vqs0EV
======================================================================
Genentech is proud to be a corporate sponsor of the UCSD-Nature Signaling Gateway.
Genentech is a leading biotechnology company that discovers, 
develops, manufactures and commercializes biotherapeutics 
for significant unmet medical needs. Fifteen of the currently
approved biotechnology products stem from or are based on
Genentech science. Genentech manufactures and commercializes 
ten biotechnology products directly in the United States. 
The company has headquarters in South San Francisco, California,
and is traded on the New York Stock Exchange under the symbol DNA.
http://ealerts.nature.com/cgi-bin24/DM/y/ekdF0Xztnp0H2W0dIO0Ev
=====================================================================
As a registered user of the Nature Publishing Group web sites, you
were selected to receive this message in the genuine belief that it
would be of interest to you.
If you no longer wish to receive news and announcements from Nature 
Publishing Group or wish to unsubscribe from the Signaling Update
email alert please update your online Nature.com account details here:
http://ealerts.nature.com/cgi-bin24/DM/y/ekdF0Xztnp0H2W0BCGZ0Ed
For further technical assistance or any other enquiries, please click here:
http://ealerts.nature.com/cgi-bin24/DM/y/ekdF0Xztnp0H2W0BByD0E5
Nature's world-wide offices:
London . Paris . Munich . New Delhi . Tokyo . Melbourne . San Diego . 
San Francisco . Washington . New York . Boston
(c) 2008 Nature Publishing Group
---------------------------------------------------------------------
 
 
 
 
 

 






 
